1. Home
  2. VTSI vs BTAI Comparison

VTSI vs BTAI Comparison

Compare VTSI & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.12

Market Cap

53.2M

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.51

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
BTAI
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
35.6M
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
VTSI
BTAI
Price
$4.12
$1.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$25.33
AVG Volume (30 Days)
25.4K
818.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$16,524,225.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
$261.81
P/E Ratio
$46.89
N/A
Revenue Growth
5.57
N/A
52 Week Low
$3.57
$1.17
52 Week High
$7.47
$8.08

Technical Indicators

Market Signals
Indicator
VTSI
BTAI
Relative Strength Index (RSI) 39.18 40.90
Support Level N/A $1.50
Resistance Level $5.15 $2.28
Average True Range (ATR) 0.21 0.11
MACD -0.00 0.00
Stochastic Oscillator 12.00 8.57

Price Performance

Historical Comparison
VTSI
BTAI

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: